The global disposable gloves market, by Material (Latex, Natural Rubber, Nitrile, Vinyl, Polyethylene, and Other Material), by Glove Type (Powdered and Non-Powdered), by Application (Medical (Examination Gloves and Surgical Gloves), Non-Medical (Food and Beverages, Industrial, and Household)) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 6,155.4 million in 2017 and is projected to exhibit a CAGR of 7.8% over the forecast period (2018 – 2026).
Medical gloves are disposable gloves used during medical examinations and procedures to minimize the cross-contamination between the patients and caregivers. This disposable gloves are part of infection control strategy. They are used as personal protective equipment to protect the wearer and/or the patient from spreading infection or illness during medical examination procedures. Disposable gloves are used for the medical diagnose or to examine patient’s body fluids such as blood, respiratory secretions, urine, vomit and feces or certain hazardous drugs or handling potentially contaminated items. Food and Drug Administration (FDA) have classified medical gloves, as lass I reserved medical devices, which requires a 510(k) premarket approval, whenever the new disposable gloves are need to introduced in the market. Natural latex glove are conventional and most commonly used disposable gloves used in medical and other industrial purposes, owing to cost-effective, easy-to-use, and bio-degradable nature.
However, potential allergic reactions from the latex gloves creates the need to use synthetic gloves such as nitrile, vinyl and polyethylene gloves. In December 2014, FDA recommended to label the medical products mentioning if it is made from natural rubber latex. If patient is allergic to the natural rubber latex, healthcare professional or care giver should choose gloves made from other synthetic materials. Moreover, increasing numbers of people suffering with allergy of natural rubber is increasing demand for synthetic disposable gloves in the market. Exposure of body tissues to the powder can cause severe airway inflammation and hypersensitivity reactions. In December 2016, FDA banned the powdered gloves, owing to risk of illness or injury to individuals exposed to the powdered gloves. The powder particles also triggers the immune response causing the granulomas or scar tissue formation, which results into surgical complications. Increasing prevalence of infectious disease worldwide and need for infection control are propelling growth of the disposable gloves market.
According to the Centers for Disease Control and Prevention (CDC), in 2014, around 17.8 million people visited to physician’s office and around 3.9 million people visited hospital outpatient department for treatment of infectious and parasitic diseases in the U.S. According to the Infectious Disease Surveillance 2014 data findings, published by European Centre for Disease Prevention and Control (ECDC) in June 2017, chlamydia infection, campylobacteriosis, salmonellosis, gonorrhea, and tuberculosis are the prominent disease reported in the 2014, which accounted for around 8, 50,000 cases and 75% of the 1.1 million reported cases of notifiable infectious diseases in the EU/EEA countries in 2014.
Browse 35 Market Data Tables and 40 Figures spread through 170 Pages and in-depth TOC on “Disposable Gloves Market by Material (Latex, Natural Rubber, Nitrile, Vinyl, Polyethylene, and Other Material), by Glove Type (Powdered and Non-Powdered), by Application (Medical (Examination Gloves and Surgical Gloves), Non-Medical (Food and Beverages, Industrial, and Household)) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026”
To know the latest trends and insights prevalent in the disposable gloves market, click the link below:
Manufactures are engaged in development of advanced gloves, which provide the protection for long period of time and are easy to use. For instance, in September 2016, Ansell launched Microflex LifeStar EC powder-free nitrile extended cuff examination gloves, which are designed extensively for the emergency healthcare professionals. Furthermore, in July 2017, Cole-Parmar launched ThinTouchPROtech Nitrile gloves, which offer the protection against the 29 chemotherapeutic drugs including Carmustine and ThioTepa. Furthermore, these gloves offers enhanced tactility over the extended period of use.
Key Takeaways of the Disposable Gloves Market: